申请人:SmithKline Corporation
公开号:US04089961A1
公开(公告)日:1978-05-16
Tricyclic quinolizidine derivatives administered internally to an animal host, in therapeutically effective amounts, produce antipsychotic activity essentially free of extrapyramidal symptoms.
三环喹啉啶衍生物在治疗有效剂量下内部给动物宿主使用,可产生基本没有锥体外系症状的抗精神病活性。